Tian‐En Li

Fudan University — China

Medicine · Health Sciences

9h-index762citations15works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(6), Cancer Mechanisms and Therapy(5), Lung Cancer Treatments and Mutations(3), Cancer, Hypoxia, and Metabolism(3), Cancer Immunotherapy and Biomarkers(2)

Publications15 total

Single-cell mapping reveals several immune subsets associated with liver metastasis of pancreatic ductal adenocarcinoma
Med·2023· 12 citedOpen Access
Supplementary Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
2023Open Access
Supplementary Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
2023Open Access
Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
2023Open Access
Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
2023Open Access
Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
Cancer Research·2022· 157 citedOpen Access
The combination of PD-1 blockade with interferon-α has a synergistic effect on hepatocellular carcinoma
Cellular and Molecular Immunology·2022· 125 citedOpen Access
Hippo/YAP signaling choreographs the tumor immune microenvironment to promote triple negative breast cancer progression via TAZ/IL-34 axis
Cancer Letters·2021· 52 cited
Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities
Theranostics·2021· 45 citedOpen Access
Hippo/YAP Signaling Choreographs The Tumor Immune Microenvironment to Promote Triple Negative Breast Cancer Progression Via TAZ/IL-34 Axis
Research Square (Research Square)·2021· 6 citedOpen Access
A Novel Immunotype-based Risk Stratification Model Predicts Postoperative Prognosis and Adjuvant TACE Benefit in Chinese Patients with Hepatocellular Carcinoma
Journal of Cancer·2021· 8 citedOpen Access
IFN-α facilitates the effect of sorafenib via shifting the M2-like polarization of TAM in hepatocellular carcinoma.
PubMed·2021· 13 citedOpen Access
PKM2 Drives Hepatocellular Carcinoma Progression by Inducing Immunosuppressive Microenvironment
Frontiers in Immunology·2020· 101 citedOpen Access
MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming
British Journal of Cancer·2019· 227 citedOpen Access
Specific prognostic factors in hepatitis B virus‐related and non‐hepatitis B virus–related intrahepatic cholangiocarcinoma after macroscopic curative resection
Journal of Surgical Oncology·2018· 16 cited

Frequent Co-authors

Qiongzhu Dong(11), Lun–Xiu Qin(11), Beiyuan Hu(8), Yan Zheng(8), Jianhua Li(8), Ying Zhu(7), Da Xu(6), Xiaotian Shen(6), Ze Zhang(6), Le Zhu(6), Tiantian Zou(5), Wei Qin(5), Yinghan Su(5), Yang Chen(5), Haoting Sun(5), Chao-Qun Wang(5), Zhengxin Wang(5), Shun Wang(5), Xufeng Wang(5), Yan Fu(5)